Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Wejde

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Human Molecular Genetics|August 14, 2003
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcomaClelia Tiziana Storlazzi, Fredrik Mertens, Antonio Nascimento, et al.
Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcomaJan Ahlén, Johan Wejde, Otte Brosjö, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2018
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortalityYingbo Lin, Nelly Seger, Yi Chen, et al.
International Journal of Oncology|December 9, 2004
Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavityWen-Hui Weng, Mikael Lerner, Dan Grandér, et al.
Journal of Clinical Pathology|April 29, 2018
Telomerase promoter mutations and copy number alterations in solitary fibrous tumoursYingbo Lin, Nelly Seger, Panagiotis Tsagkozis, et al.
Genes, Chromosomes & Cancer|May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcomaIoannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
The American Journal of Pathology|April 28, 2004
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)Anna Dahlén, Christopher D M Fletcher, Fredrik Mertens, et al.
The American Journal of Surgical Pathology|May 20, 2020
Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative AnalysisYin P Hung, Julio A Diaz-Perez, Gregory M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of SarcomaIngegerd Öfverholm, Karin Wallander, Cecilia Haglund, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Human Molecular Genetics|August 14, 2003
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcomaClelia Tiziana Storlazzi, Fredrik Mertens, Antonio Nascimento, et al.
Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcomaJan Ahlén, Johan Wejde, Otte Brosjö, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2018
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortalityYingbo Lin, Nelly Seger, Yi Chen, et al.
International Journal of Oncology|December 9, 2004
Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavityWen-Hui Weng, Mikael Lerner, Dan Grandér, et al.
Journal of Clinical Pathology|April 29, 2018
Telomerase promoter mutations and copy number alterations in solitary fibrous tumoursYingbo Lin, Nelly Seger, Panagiotis Tsagkozis, et al.
Genes, Chromosomes & Cancer|May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcomaIoannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
The American Journal of Pathology|April 28, 2004
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)Anna Dahlén, Christopher D M Fletcher, Fredrik Mertens, et al.
The American Journal of Surgical Pathology|May 20, 2020
Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative AnalysisYin P Hung, Julio A Diaz-Perez, Gregory M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of SarcomaIngegerd Öfverholm, Karin Wallander, Cecilia Haglund, et al.
Pageof 3